33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ROCK1 orchestrates B-cell differentiation under stress
    Meeting Abstract

    Rivera-Correa, J.; Gupta, S.; Ricker, E.; Flores-Castro, D.; Jenkins, D.; Vulcano, S.; Pannellini, T.; Miele, M.; Li, Z.; Zamponi, N.; more...
    Arthritis & Rheumatology (2023)

    Fulltext@MSK | Save
  • ENGOT-EN20/GOG-3083/XPORT-EC-042 a phase 3, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy for patients with P53 wild-type, advanced or recurrent endometrial carcinoma
    Meeting Abstract

    Vergote, I.; Mirza, M. R.; Coleman, R.; Fidalgo, J. P.; Monk, B.; Valabrega, G.; Slomovitz, B.; Van Gorp, T.; Moore, K.; Sehouli, J.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Surgical approach to cervical cancer and considerations for nerve sparing radical hysterectomy
    Meeting Abstract

    Praiss, A.; Leitao, M.; Kim, S.; Zammarrelli, B.; Abu-Rustum, N.; Sonoda, Y.
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Phase 1/2 study of galinpepimut-S plus pembrolizumab combination in patients with WT1+platinum-resistant ovarian cancer in 2nd/3rd line of therapy
    Meeting Abstract

    Ocearbhaill, R.; Holmes, J.; Bastos, B.; Fu, S. Q.; Muenzen, R.; Cohen, J.; Cicic, D.; Ali, S.
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • A phase 2, open-label, single-arm, prospective, multi-center study of nab-sirolimus plus letrozole in advanced or recurrent endometrioid endometrial cancer
    Meeting Abstract

    Dockery, L.; Priebe, A.; Duska, L.; Green, A.; Mathews, C.; Musa, F.; O'Malley, D.; Puechl, A.; Ding, L.; Schmid, A.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • First-in-human phase 1/2 study of ubamatamab, a MUC16XCD3 bispecific antibody, administered alone or in combination with cemiplimab in patients with recurrent ovarian cancer
    Meeting Abstract

    Moore, K.; Bouberhan, S.; Hamilton, E.; Liu, J. Y.; O'Cearbhaill, R.; O'Malley, D.; Papadimitriou, K.; Schröder, D.; Van Nieuwenhuysen, E.; Yoo, S. Y.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Radiation quality and workflow in NRG GY017: Anti PD-L1 (atezolizumab) as an immune primer or concurrently with RT for node positive locally advanced cervical cancer
    Meeting Abstract

    Mayadev, J.; Deng, W.; Zamarin, D.; Lankes, H.; Kim, H.; Chino, J.; Banberry, B.; Sherry, N.; Ghamande, S.; Ferguson, C.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Outcomes associated with postoperative chemotherapy following pelvic exenteration for recurrent or persistent gynecologic malignancies
    Meeting Abstract

    Zammarrelli, B.; Saini, A.; Rios-Doria, E.; Yeoshoua, E.; Jewell, E.; Tew, W.; Abu-Rustum, N.; Leitao, M.; Sonoda, Y.; O'Cearbhaill, R.
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • The effect of known pathological risk factors on the incidence of metastatic lymph nodes and survival in early-stage vulvar cancer- SEER analysis
    Meeting Abstract

    Nahshon, C.; Leitao, M.; Lavie, O.; Segev, Y.
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save
  • Clinicopathologic and genomic analysis of uterine serous carcinomas arising from endometrial hyperplasia
    Meeting Abstract

    Sia, T.; Allison, D.; Paula, A. D.; Da Silva, E.; Ye, Q.; Selenica, P.; Pareja Zea, F.; Green, H.; Abu-Rustum, N.; Weigelt, B.; more...
    International Journal of Gynecological Cancer (2023)

    Fulltext@MSK | Save